KEVIN HSU, MD

Plain English
This study looked at how well large language models (computer programs that generate text) handle conversations about alcohol and substance use disorders. Researchers found that 35.4% of responses from these models included stigmatizing language, which can be harmful to patients, but when they refined the questions given to the models, this dropped to only 6.3%. This is important because using non-stigmatizing language can lead to better communication and care for individuals struggling with these issues. Who this helps: Patients with alcohol and substance use disorders.

Plain English
This study looked at how well a faster MRI technique can detect specific brain issues related to a treatment for Alzheimer's called anti-amyloid-beta immunotherapy. It compared standard MRI methods to quicker alternatives that reduced scan times by 86% and 83%, respectively, while still maintaining similar effectiveness in identifying problems like cerebral microbleeds and superficial siderosis. The results showed that, while the faster techniques had slightly lower image quality and agreement among reviewers, they performed well enough to be useful, which could help increase the number of patients who can be screened for potential treatment side effects. Who this helps: This helps patients undergoing anti-amyloid-beta immunotherapy by making MRI screenings quicker and more efficient.

Plain English
This study looked at how symptoms and daily activities impact caregivers of patients with a heart condition called ATTR-CM. It found that caregivers reported feeling much more burdened when patients had symptoms like fatigue, leg weakness, or if they couldn’t perform daily tasks such as bathing or cooking. Specifically, caregivers of patients with these issues had significantly higher stress and anxiety scores, highlighting the emotional impact on those caring for these patients. Who this helps: This information benefits caregivers and healthcare providers by highlighting the challenges faced by both patients and those who care for them.

Plain English
This research studied the effects of a new serum containing 2-mercaptonicotinoyl glycine (2-MNG) on skin tone and dark spots, particularly among 74 women in China. The serum was found to significantly improve skin tone, reduce dark spots, make skin brighter, and increase hydration over 4 to 8 weeks. This matters because it offers an effective alternative for people looking to improve their skin appearance without harsh chemicals. Who this helps: Patients dealing with hyperpigmentation and uneven skin tone.

Plain English
This study looked at a new treatment called Alnuctamab for patients with multiple myeloma who had already tried other therapies without success. Out of 95 patients, nearly 59% saw their cancer shrink, and 71% of those receiving the recommended dose had a positive response, with half of them showing no detectable cancer left. This is important because it suggests that Alnuctamab may be a safer and effective option for those with difficult-to-treat multiple myeloma. Who this helps: This helps patients with relapsed or refractory multiple myeloma.

Plain English
Researchers studied a 9-month-old dog that had severe eye inflammation and swelling, as well as pneumonia in its lungs. After treating the dog unsuccessfully with medication, the veterinarians removed the dog's eye, which allowed them to identify a specific bacterium that caused the infection. This discovery shows that advanced DNA sequencing can help identify hard-to-detect bacteria in animals, which can improve treatment for serious infections. Who this helps: This benefits veterinarians and pet owners dealing with severe eye infections in dogs.

Plain English
This study looked at a new questionnaire called the ATTR-QOL, designed to measure how transthyretin amyloidosis (ATTR) affects patients' quality of life. Researchers found that the questionnaire worked well to show how different stages of the disease and other health measures impacted the patients, with 194 individuals participating. Most patients were in the early stages of the disease, and the results highlighted that the ATTR-QOL can successfully identify the broader effects of ATTR on daily life and health. Who this helps: This helps patients with ATTR and their doctors understand the disease's impact on quality of life.

Plain English
This study looked at how a substance called nattokinase (NK) can help protect the brain after a stroke. Researchers found that giving rats nattokinase before a stroke significantly reduced the size of brain damage and improved their ability to return to normal activities. Specifically, rats given NK had a 30% smaller area of brain injury compared to those who didn’t receive it, and clotting time was noticeably longer, indicating NK helps blood flow. Who this helps: This benefits patients who have had a stroke and may improve treatment options for doctors.

Plain English
This study looked at how differences in medical imaging settings and methods affect the performance of artificial intelligence (AI) models used for diagnosing issues like strokes and brain injuries. Researchers analyzed 1,177 CT scans and found that the type of AI model used had the biggest impact on accuracy, but the scanner manufacturer and slice thickness also mattered. For instance, thinner slice imaging was better for detecting brain bleeding and masses, while the scanner made a difference in detecting bleeding and strokes. Who this helps: This research benefits doctors and radiologists by improving how AI is used in diagnosing brain conditions.

Plain English
This study looked at how malaria-carrying mosquitoes are likely to spread in the Greater Horn of Africa, focusing on factors that affect their habitats. The researchers found that the spread of a new type of urban malaria mosquito has significantly increased, going from 20 kilometers per year in 2012 to over 120 kilometers per year by 2024. These findings are crucial because they help identify areas that are at risk for malaria outbreaks, particularly as climate change may make more regions suitable for mosquito habitats. Who this helps: This helps public health officials and healthcare providers in planning and implementing effective malaria control strategies.

Plain English
This study looked at factors that predict how patients with AL amyloidosis will progress, especially in light of new treatments like daratumumab that have dramatically increased survival rates to 76% over five years. The researchers found that traditional methods for assessing risk are outdated and that new methods—like tracking minimal residual disease and using cardiac imaging—might be more effective in identifying patients who are at high risk for progression. Understanding these factors is crucial because it helps doctors provide better-targeted treatments to patients who need them most. Who this helps: Patients with AL amyloidosis who may require tailored interventions to manage their disease effectively.

Plain English
This research paper looks at transthyretin amyloidosis (ATTR), a serious disease that can affect the heart and other organs. It found that more patients are being diagnosed with ATTR, and understanding how the disease progresses is important for choosing the right treatments. The study highlights the need for better monitoring tools to track how the disease affects not just the heart but also other parts of the body. Who this helps: This benefits patients with ATTR and their doctors in managing their treatment.

Plain English
Researchers created and tested a new tool called the Liver Disease Stigma Scale (LDSS) to measure stigma related to chronic liver disease, especially focusing on those with alcohol-associated liver disease (ALD). In a study involving 211 patients, those with ALD reported significantly higher levels of stigma compared to those with other liver conditions, with internalized stigma scores averaging 2.34 for ALD patients versus 1.50 for others. This matters because understanding stigma can improve patient care and encourage more people to seek help, particularly in vulnerable populations. Who this helps: Patients with chronic liver disease and their healthcare providers.

Plain English
This study looked at how electroacupuncture and Low-Level Laser Therapy (LLLT) helped a 62-year-old woman with Ménière's Disease, a condition that causes dizziness, ringing in the ears, and hearing loss. Before treatment, she suffered from severe vertigo attacks, averaging two to three times a week, totaling 28 attacks over two months. After just nine sessions of these therapies, her vertigo attacks stopped completely, along with improvements in her tinnitus and overall quality of life. Who this helps: This helps patients with Ménière's Disease seeking alternative treatments for their symptoms.

Plain English
This study looked at the different methods used for cataract surgery in animals, specifically comparing one-handed and two-handed techniques. The authors found that most veterinary eye surgeons continue to use the one-handed method, often because they weren't trained in the two-handed technique during their residency. This matters because two-handed methods are believed to be more effective and could lead to better outcomes for animal patients. Who this helps: This helps veterinarians and their patients by improving surgical techniques and potentially enhancing the quality of care for animals with cataracts.

Plain English
This study looked at how patients with advanced melanoma and lung cancer, along with their caregivers, understand the goals of immunotherapy and deal with the uncertainty about their treatment. The researchers interviewed 42 patients and 10 caregivers, finding that many had hopeful expectations about the treatment, especially those with melanoma, but also faced significant disappointment when their health didn’t improve. This matters because patients and caregivers need better support and clearer communication about what to expect from immunotherapy, especially when there is uncertainty. Who this helps: This helps patients with cancer and their caregivers.

Plain English
This study focused on improving a method for developing CAR T cell therapies used to treat certain types of leukemia by enhancing the delivery system called adeno-associated virus (AAV). The researchers created a new way to select better AAV variants, which resulted in two new types, AAV-T1 and AAV-T2, that were five times more effective in getting the CAR construct into T cells compared to the previous AAV6. This enhancement could mean that lower doses of the vector are needed to produce potent T cells that can target brain tumors effectively. Who this helps: This benefits patients with leukemia and brain tumors who may receive more effective treatments.

Plain English
This study examined a specific blood type known as GP.Mur, which has higher levels of a protein called AE1 on red blood cells. Researchers found that individuals with this blood type also had lower levels of nitric oxide metabolites in their blood and were more likely to have higher blood pressure, making them naturally hypertensive. This matters because understanding the connection between GP.Mur, AE1 levels, and hypertension can lead to new treatment strategies for managing high blood pressure, especially in Southeast Asian populations where this blood type is common. Who this helps: Patients with the GP.Mur blood type, particularly those at risk for hypertension.

Plain English
This study looked at how variations in specific genes from both donors and patients affect the chances of cancer returning and mortality after a particular type of stem cell transplant called haploidentical transplantation. They analyzed data from 1,629 transplant cases and found that patients receiving transplants from certain donors had a significantly lower risk of relapse (51% lower) and a reduced risk of mortality with a specific gene combination (hazard ratio of 0.62). Understanding these genetic factors could lead to better treatment strategies and improve outcomes for patients undergoing this type of transplant. Who this helps: This helps patients undergoing haploidentical stem cell transplants.

Plain English
Researchers studied an educational program called "UPLIFT," which includes a video and a list of questions to help patients with advanced cancer and their caregivers understand the risks and benefits of a specific type of cancer treatment known as immune checkpoint inhibitors (ICIs). Out of 178 eligible patients, 130 participated, and those who received UPLIFT showed a 9% increase in knowledge about ICIs at 72 hours compared to those who received standard care. The program was well-received, with 94% of participants feeling comfortable using it, and those who participated asked more questions during their doctors’ visits. Who this helps: This helps cancer patients and their caregivers understand their treatment options better.

Plain English
This study looked at the financial struggles faced by patients with transthyretin amyloidosis, a serious disease, and found that 55% of participants reported significant financial stress due to their treatment costs. Younger, non-white patients and those with lower incomes were particularly affected, often delaying treatment or borrowing money to pay for care. This matters because the financial burden can prevent patients from getting the help they need, impacting their health and quality of life. Who this helps: This helps patients with transthyretin amyloidosis and their families.

Plain English
This research examined how imaging technology can be used in clinical trials to better understand two rare diseases: light chain amyloidosis and transthyretin amyloidosis. The study found that advanced imaging techniques can effectively detect the buildup of amyloid proteins in organs, particularly the heart, which is critical for assessing how well treatments are working. This matters because it can lead to more accurate evaluations of disease progression and treatment responses, ultimately improving patient outcomes. Who this helps: Patients with amyloidosis and their doctors.

Plain English
This study looked at how effective partner notification (PN) programs are in reducing gonorrhea rates, particularly among men who have sex with men. Researchers found that for every 10% increase in PN coverage, there was a 3% reduction in gonorrhea cases. This means that improving PN can significantly help lower the number of new infections, showing that such programs work well in various local conditions. Who this helps: This helps patients, especially those at higher risk of gonorrhea, by promoting better health outcomes through effective notification programs.

Plain English
This study looked at a questionnaire designed to measure the quality of life for people with transthyretin (ATTR) amyloidosis, focusing on how the disease affects daily activities, physical health, social roles, and emotional well-being. Researchers tested the reliability of the questionnaire by surveying 233 patients, finding that it consistently measures impacts on quality of life with high accuracy and validity scores ranging from 0.85 to 0.97. This is important because it provides a reliable tool for understanding how ATTR amyloidosis affects patients and can help tailor better care and support for them. Who this helps: This helps patients living with ATTR amyloidosis and their doctors by offering a better way to assess their quality of life and needs.

Plain English
This study looked at the immune system's recovery in bone marrow and blood after a type of cancer treatment called hematopoietic transplantation. Researchers found that natural killer (NK) cells, which help fight cancer, were more prevalent in the bone marrow than in blood by 100 days post-transplant. This is important because it shows that the bone marrow has a different response than blood and that having more specific types of immune cells in the marrow relates to better outcomes, as patients who did not relapse had higher markers of certain immune cells. Who this helps: This helps patients undergoing hematopoietic transplantation for blood cancers.

Plain English
This study looked at how untreated transthyretin amyloid cardiomyopathy (ATTR-CM) affects patients and their caregivers by analyzing responses from 208 patients and their caregivers in different countries. Researchers found that symptoms like heart failure, leg weakness, older age, and being female significantly increased the burden of the disease on patients. Additionally, caregivers reported feeling more burdened when patients had poorer health scores. These findings highlight the importance of addressing physical symptoms in patients to also support their caregivers. Who this helps: This helps patients with ATTR-CM and their caregivers.

Plain English
This study looked at how using a special facial serum before and after a laser treatment called ablative fractional CO2 laser (AFCO) helped 72 women with acne scars recover from their procedure. The results showed that using the serum significantly improved skin hydration and reduced water loss, with better results in the serum group compared to the control group at multiple points in time, particularly after the treatment. This matters because it shows that the serum can help people recover faster from laser treatments and reduce discomfort. Who this helps: This helps patients who undergo laser skin treatments.

Plain English
This research looked at how age and race affect the stage at which cervical cancer is diagnosed. The study found that women aged 65 and older are much more likely (1.6 times) to be diagnosed with advanced cervical cancer compared to younger women, and Black women specifically have a 16% higher chance of late-stage diagnosis than White women. These results highlight serious gaps in cervical cancer screenings and follow-up care, especially for older women and women of color, which can lead to worse health outcomes. Who this helps: This information benefits patients, especially older women and women of color who may be at risk for late-stage cervical cancer.

Plain English
This study looked at the effects of a moisturizing cream and a facial mask on skin problems caused by wearing medical masks. It found that using either the cream alone or the cream with the mask significantly improved skin hydration and reduced dryness compared to untreated skin. Specifically, the cream alone reduced water loss from the skin by about 2.95 grams per hour, while the cream plus mask showed an even greater improvement of 4.67 grams per hour. This is important because it means that these products can help people who experience skin issues from prolonged mask use feel more comfortable. Who this helps: Patients who wear medical masks frequently, such as healthcare workers and individuals in high-risk environments.

Plain English
This study looked at the long-term health outcomes of COVID-19 patients who experienced neurological issues during their hospital stay, comparing them to those who did not. After three years, it found that patients with neurological complications were more likely to need rehabilitation or nursing care after discharge (10.39% vs. 3.34% and 35.75% vs. 25.35%, respectively), had higher readmission rates (65.70% vs. 60.72%), and were more likely to die after leaving the hospital (2.35 times more at risk). These results highlight the need for special attention and follow-up for COVID-19 patients with neurological symptoms, as they face greater health challenges in recovery. Who this helps: Patients with COVID-19 and their healthcare providers.

Plain English
This research paper focuses on improving clinical trials for AL amyloidosis, a rare disease where harmful proteins build up in organs. Researchers created a structured plan to develop new ways of measuring patient outcomes, particularly to address the effects on multiple organ systems and overall quality of life. By validating these new measurement strategies, the goal is to make it easier for new drugs to be tested effectively and to support patients better; this type of research is crucial for creating treatments that truly meet patients' needs. Who this helps: Patients with AL amyloidosis.

Plain English
This study looked at the effects of specific proteins in red blood cells on blood pressure and gas exchange. Researchers found that people with a certain blood type (GPMur), which has more of these proteins, had higher blood pressure and reduced levels of a molecule called nitric oxide that helps blood vessels relax. Specifically, those with GPMur blood type had blood pressure that was more closely linked to their hemoglobin levels. Who this helps: This research helps patients with the GPMur blood type and healthcare providers in understanding their blood pressure regulation.

Plain English
This study evaluated how well artificial intelligence (AI) models can help identify brain problems using brain scans from multiple hospitals. The models performed poorly, with accuracy for detecting brain issues only reaching between 49% and 59%, and only a couple of teams effectively using AI to determine if findings were age-appropriate or required immediate medical attention. These results highlight that AI technologies are not yet reliable enough to be used in real-world medical settings, emphasizing the need for more testing before they can be confidently integrated into healthcare. Who this helps: This helps doctors and medical institutions ensure patient safety and accurate diagnoses.

Plain English
This study focused on finding ways to reduce inflammation and retinal damage in a condition called proliferative vitreoretinopathy (PVR), which can occur after retinal detachment. Researchers tested two drugs that activate a specific receptor in the body, finding that one drug, HU-308, was particularly effective at reducing inflammation and cell death in the eye. Specifically, both drugs helped lessen harmful signals and cell damage associated with PVR, indicating that targeting this receptor could be beneficial in treating eye diseases. Who this helps: This research benefits patients at risk of retinal damage and doctors seeking effective treatments for eye diseases.

Plain English
This study explored a new way to shape and join metal using a technique called Resonance-Assisted Deposition (RAD). The researchers found that by applying a special type of strain, they could shape metals like aluminum more efficiently, using less energy compared to traditional methods. This is important because it can lead to manufacturing processes that are faster, cheaper, and better for the environment. Who this helps: This benefits manufacturers looking for more efficient metal production methods.

Plain English
This paper discusses a recent meeting aimed at improving drug development for transthyretin amyloidosis (ATTR), a rare and complex disease where abnormal proteins build up in the body, affecting multiple organs. The meeting highlighted the need for better clinical trial designs that use up-to-date information, emphasizing that while patients are being diagnosed earlier and have milder disease, historical data from past treatments is no longer relevant. The researchers believe that understanding the current state of the disease and using real-world data will help create more effective treatments. Who this helps: This helps patients with ATTR and the doctors treating them.

Plain English
This study looked at how a protein called soluble HLA-G (sHLA-G) affects blood vessel formation in multiple myeloma (MM), a type of cancer that often comes back after treatment. Researchers studied 57 patients and found that when sHLA-G was degraded, blood vessel growth increased, which is linked to cancer relapse. Specifically, they showed that low oxygen levels in the bone marrow increase sHLA-G's activity, and when stimulated with another molecule, both sHLA-G and another factor could be broken down, potentially leading to more blood vessel growth. Who this helps: This research benefits patients with multiple myeloma by identifying new targets for therapies that could reduce the risk of relapse.

Plain English
This study looked at a new drug called alnuctamab, which is designed to help treat a type of blood cancer called multiple myeloma. Researchers tested different doses and found that injecting it under the skin (subcutaneous) rather than through a vein (intravenous) improved safety and patient responses to treatment. Specifically, they determined that a recommended dose of 30 mg under the skin is likely to be effective while reducing side effects. Who this helps: This helps patients with relapsed or refractory multiple myeloma by providing a safer and potentially more effective treatment option.

Plain English
This study looked at how changing the threshold for when to switch antibiotics for treating gonorrhea in men who have sex with men impacts health outcomes and costs. The research found that adjusting the switch threshold from 1% to 10% didn’t significantly change the number of gonorrhea cases or overall costs, but a lower threshold (1% to 2%) could improve health benefits if new antibiotics or drug susceptibility tests become available. This is important because it can help ensure that infections are treated effectively and minimize unnecessary costs as we adapt to antibiotic resistance. Who this helps: This benefits patients with gonorrhea and healthcare providers involved in their treatment.

Plain English
This study looked at how patients with advanced lung cancer or melanoma and their caregivers learn about the side effects of immune checkpoint inhibitors (ICIs) used in their treatment. Out of 42 participants, many found the information about potential side effects overwhelming, but nearly 65% went ahead with treatment after encouragement from their doctors, seeing side effects as a sign that the treatment was working. Improving how this information is communicated could help people feel more prepared and hopeful about their treatment. Who this helps: This helps patients and their caregivers by improving their understanding of treatment side effects and enhancing their coping strategies.

Plain English
This study looked at how patients with advanced lung cancer or melanoma and their caregivers learn about and handle the side effects of immune checkpoint inhibitors, a type of cancer treatment. Researchers interviewed 42 patients and caregivers and found that while patients received a lot of information about potential side effects, it often felt overwhelming. Despite their fears, many patients were motivated to continue treatment because their doctors encouraged them, especially since they viewed side effects as a sign that the treatment was working. Who this helps: This research benefits patients receiving immune checkpoint inhibitors and their caregivers by highlighting ways to improve communication about treatment side effects.

Plain English
This study looked at how pulmonary embolism (a blockage in the lungs) is treated in patients aged 85 and older, compared to younger age groups. Researchers found that 53.4% of all patients received a blood thinner called Direct Oral Anticoagulants (DOACs), while the most common treatment for the oldest patients was a different blood thinner combined with warfarin, prescribed to 46.2% of them. The overall risks of serious complications, like major bleeding, were low at just 1.7%, and the outcomes were similar across all age groups, showing that older patients can receive the same treatment without increased risk. Who this helps: This helps doctors understand how to treat very elderly patients with pulmonary embolism effectively and safely.

Plain English
This study looked at how nattokinase, a substance from fermented soybeans, affects rats with Alzheimer’s disease caused by aluminum and another chemical. The researchers found that giving rats nattokinase improved their brain structure and reduced harmful proteins associated with Alzheimer’s by increasing their levels in the spinal fluid. Specifically, treatment led to better brain volume and some improvement in memory tests. Who this helps: This helps patients with Alzheimer's disease and their caregivers.

Plain English
This study looked at how gonorrhea cases in Massachusetts are treated. Researchers found that most cases (about 82% of the 208 providers) are handled by general medical providers in community health centers and emergency departments rather than specialists trained in infectious diseases. This is important because it shows a need to quickly put new treatment and prevention strategies into practice where they can have the most impact on patients with gonorrhea. Who this helps: This research benefits healthcare providers and patients who have or are at risk for gonorrhea.

Plain English
This study examined how communities in Nepal, Ethiopia, Sierra Leone, and Liberia define and measure their healthcare resilience during crises like outbreaks and natural disasters. Researchers talked to 486 people, including community members and health officials, to gather their insights. They found that key factors for community resilience include preparedness, response strategies, community involvement, and strong health systems; participants identified 193 possible indicators to measure resilience across various areas. Who this helps: This research helps health policymakers and community leaders improve healthcare systems to better withstand emergencies.

Plain English
This study looked at a specific type of immune cells called CD8αNK cells in people who were exposed to tuberculosis (TB) in Haiti. Researchers found that individuals who seemed resistant to TB had higher levels of these cells, but as the infection progressed in others, the number of CD8αNK cells decreased. This research matters because it highlights the role of CD8αNK cells in fighting off TB, potentially leading to better treatments or prevention strategies. Who this helps: This helps patients at risk for tuberculosis and healthcare providers managing TB cases.